Combating drug-resistant tuberculosis: the unexpected benefits of bedaquiline

被引：3
|
作者：
Furin, Jennifer [1 ]
Diacon, Andreas H. [2 ]
Andries, Koen [3 ]
机构：
[1] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA
[2] Univ Stellenbosch, Fac Hlth Sci, Dept Biomed Sci, Tygerberg, South Africa
[3] Janssen Pharmaceut, Infect Dis BVBA, Beerse, Belgium
来源：
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE | 2017年 / 21卷 / 01期
关键词：
D O I：
10.5588/ijtld.16.0768
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：4 / 5
页数：2
相关论文
共 50 条
  • [21] Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis
    Yates, Tom A.
    LANCET RESPIRATORY MEDICINE, 2018, 6 (12): : E56 - E56
  • [22] Primary Bedaquiline Resistance Among Cases of Drug-Resistant Tuberculosis in Taiwan
    Wu, Sheng-Han
    Chan, Hsin-Hua
    Hsiao, Hseuh-Chien
    Jou, Ruwen
    FRONTIERS IN MICROBIOLOGY, 2021, 12
  • [23] Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis in China
    Han, X.
    Chen, X.
    Sha, W.
    Zhang, X.
    Qiu, L.
    Wang, J.
    Wu, G.
    Yao, L.
    Lv, Y.
    Zhang, X.
    Zhou, J.
    Tang, S.
    Chu, N.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2020, 24 (08) : 789 - +
  • [24] A cost comparison of amikacin therapy with bedaquiline, for drug-resistant tuberculosis in the UK
    Manalan, Kavina
    Green, Nathan
    Arnold, Amber
    Cooke, Graham S.
    Dedicoat, Martin
    Lipman, Marc
    Loyse, Angela
    Harrison, Tom S.
    Kon, Onn Min
    JOURNAL OF INFECTION, 2020, 80 (01) : 38 - 41
  • [25] A bedaquiline, pretomanid, moxifloxacin, and pyrazinamide regimen for drug-susceptible and drug-resistant tuberculosis
    Deng, Guofang
    Fu, Liang
    LANCET INFECTIOUS DISEASES, 2024, 24 (09): : 940 - 941
  • [26] Administration of linezolid, bedaquiline and imipenem in treatment of patients with extensively drug-resistant tuberculosis
    Nikolayan, L. T.
    Yeghiazaryan, L. M.
    Hayrapetyan, A. O.
    Beglaryan, N. R.
    Poghosyan, V. R.
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [27] Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis Reply
    Ndjeka, Norbert
    LANCET RESPIRATORY MEDICINE, 2018, 6 (12): : E57 - E57
  • [28] Compassionate use of bedaquiline in highly drug-resistant tuberculosis patients in Mumbai, India
    Udwadia, Zarir F.
    Ganatra, Shashank
    Mullerpattan, Jai B.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (03)
  • [29] Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosis
    Rangnekar, Bhamini
    Momin, Mohammad A. M.
    Eedara, Basanth Babu
    Sinha, Shubhra
    Das, Shyamal C.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 570
  • [30] Dry powder formulation combining bedaquiline with pyrazinamide for latent and drug-resistant tuberculosis
    Momin, Mohammad A. M.
    Rangnekar, Bhamini
    Larson, Ian
    Sinha, Shubhra
    Das, Shyamal C.
    ADVANCED POWDER TECHNOLOGY, 2019, 30 (11) : 2473 - 2482
12345